VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XRTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XRTXXORTX Therapeutics Inc.
$2.04$568118
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksXRTXQuarterly Financials

XORTX Therapeutics Inc. (XRTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

XORTX Therapeutics Inc. (XRTX) quarterly income statement — complete revenue, gross profit & net income history

XRTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold25.49K000000043.33K33.18K22.09K43K90.41K29.25K28.79K12.45K4.78K4.74K4.53K4.37K
COGS % of Revenue--------------------
Gross Profit-25.49K0000000-43.33K-33.18K-22.09K-43K-90.41K-29.25K-28.79K-12.45K-4.78K-4.74K-4.53K-4.37K
Gross Margin %--------------------
Gross Profit Growth %----100%100%100%100%52.07%-13.45%23.28%-245.3%-1791.09%-517.11%-536.06%-184.79%-12.65%---
Operating Expenses786.4K686.42K716.2K889.95K963.46K661.26K874.75K1.49M1.09M983.67K1.49M1.76M1.91M3.61M2.74M3.38M3.64M1.61M404.88K865.45K
OpEx % of Revenue--------------------
Selling, General & Admin753.75K495.11K392.94K465.83K477.8K407.03K546.63K817.91K695.9K684.5K712.23K1.05M510.46K1M793.87K1.51M1.2M1.17M18.38K834.65K
SG&A % of Revenue--------------------
Research & Development32.65K54.86K57.01K186.75K276.31K7.76K34.74K92.61K99.75K182.69K764.13K667.91K1.05M2.58M1.92M1.86M2.44M430.95K381.97K26.42K
R&D % of Revenue--------------------
Other Operating Expenses0136.44K266.25K237.37K209.35K246.47K293.38K608.1K000000000000
Operating Income-811.89K-686.42K-716.2K-889.95K-963.46K-661.26K0-3.12M-795.65K-862.22K-1.49M-1.76M-1.92M125.35K-2.7M-2.83M-3.26M-1.32M-404.88K-763.92K
Operating Margin %--------------------
Operating Income Growth %15.73%-3.8%-71.49%-21.09%23.31%100%-77.54%58.47%-787.85%44.97%37.83%41.23%109.49%-567.02%-270.18%-496.15%-282.66%-6.03%-105.97%
EBITDA-786.4K-657.3K-686.81K-862.32K-937.47K-635.12K-848.8K-3.08M-763.52K-829.05K-1.47M-1.73M-1.85M154.59K-2.68M-2.82M-3.26M-1.32M-400.35K-759.54K
EBITDA Margin %--------------------
EBITDA Growth %16.11%-3.49%19.08%71.97%-22.78%23.39%42.24%-78.21%58.7%-636.27%45.14%38.75%43.21%111.75%-569.05%-271.03%-500.12%-287.05%-6.28%-107.64%
D&A (Non-Cash Add-back)25.49K29.11K29.39K27.63K25.98K26.14K25.95K45.22K32.13K33.18K16.47K32.02K66.85K29.25K22.06K9.76K3.78K4.74K4.53K4.37K
EBIT-811.89K-686.42K-716.2K-889.95K-963.46K-661.26K-874.75K-1.49M-1.09M-983.67K-1.39M-1.76M-1.91M155.89K-2.1M-2.65M-2.88M7.13M-317.42K-697.98K
Net Interest Income1.61K3.92K7.2K12.33K18.42K25.33K29.02K35.95K31.6K49.81K63.61K73.31K66.8K54.09K35.46K11.76K2.65K65.9K-1.08K-536
Interest Income1.61K3.92K7.2K12.33K18.42K70.43K29.02K35.95K31.6K49.81K63.61K73.31K66.8K72.92K46.28K11.76K2.65K65.9K299129
Interest Expense000000000000018.83K10.82K0001.38K665
Other Income/Expense14.62K95.95K66.73K172.25K264.78K783.8K-587.01K3.29M-2.22M3.56M152.67K66.32K83.72K-2.31M1.5M1.59M-163.6K10.42M-7.95M545.47K
Pretax Income-797.27K-590.46K-649.47K-717.7K-698.67K122.53K-587.01K170.07K-3.02M2.7M-1.33M-1.69M-1.83M-2.19M-1.2M-1.24M-3.42M9.09M-8.35M-218.45K
Pretax Margin %--------------------
Income Tax000000001.05M0455.02K000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%-34.86%0%-34.13%0%0%0%0%0%0%0%0%0%
Net Income-797.27K-590.46K-649.47K-717.7K-698.67K122.53K-587.01K170.07K-3.02M2.7M-1.33M-1.69M-1.83M-2.92M-1.2M-1.24M-2.7M9.09M-8.35M-218.45K
Net Margin %--------------------
Net Income Growth %-14.11%-581.87%-10.64%-522.01%76.86%-95.46%55.98%110.05%-64.79%192.5%-11.38%-36.57%32.24%-132.09%85.67%-467.12%-24.4%2108.78%-1866.21%41.55%
Net Income (Continuing)-797.27K-590.46K-649.47K-717.7K-698.67K122.53K-587.01K170.07K-4.07M2.7M-1.79M-1.69M-1.83M-2.19M-1.2M-1.24M-3.42M9.09M-8.35M-218.45K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.57-2.37-3.25-4.75-4.750.93-5.001.75-31.0030.50-16.75-21.25-17.50-45.00-20.75-27.50-47.25157.50-157.00-5.25
EPS Growth %88%-356.22%35%-371.43%84.68%-96.97%70.15%108.24%-77.14%167.78%19.28%22.73%62.96%-128.57%86.78%-423.81%20.92%1167.8%-1470%57.14%
EPS (Basic)-0.57-2.37-3.25-4.75-4.750.93-5.001.75-31.0030.50-16.75-21.25-23.75-45.00-20.75-27.50-47.25157.50-157.00-5.25
Diluted Shares Outstanding1.39M262.43K194.26K151.53K149.49K132.31K116.14K116.14K97.17K79.95K79.96K79.95K77.18K63.59K57.73K57.73K57.73K54.8K41.78K41.67K
Basic Shares Outstanding1.39M262.43K194.26K151.53K149.49K132.31K116.14K116.14K97.17K79.95K79.95K79.95K77.18K63.52K57.73K57.73K57.73K54.8K41.78K41.67K
Dividend Payout Ratio--------------------